The prognostic value of Diarem and AD-Diarem in patients with type 2 diabetes mellitus after bariatric surgery

Introduction. Bariatric surgery shows excellent results in the treatment of obesity and comorbidities including type 2 diabetes. To predict the effect of surgical treatment of type 2 diabetes mellitus, several scales have been proposed, including DiaRem and Ad-DiaRem.Materials and methods of research. Based on a retrospective analysis study, 38 patients with type 2 diabetes were identified after bariatric surgery with a follow-up period of at least 1 year. The KNIME Analytics Platform 4.3.6 (KNIME AG, Switzerland) was used for data processing.Treatment results. Among 38 patients, 12,8 % achieved partial remission of diabetes, 52,6 % complete remission, and 31,6 % did not achieve remission. According to the DiaRem, no significant results were detected in the remission groups (χ2 = 6,76, DF = 4, p-value = 0,15). AUC = 0,744, k = 0,383. DiaRem scale have a low predictive value. A significant result was obtained on the Ad-DiaRem (χ2 = 22,0, DF = 4, p-value = 0,0002). AUC = 0,88, k = 0,632. Ad-DiaRem predictive value is high.Conclusion. The Ad-DiaRem have a better predictive value. Ease of use, good prognostic effect allows us to recommend Ad-DiaRem before bariatric treatment to. Duration of diabetes mellitus and number of hypoglycemic drugs taken seems to be one of the crucial factors in prognosis of DM remission.